142 related articles for article (PubMed ID: 14123615)
21. The complement system of man. 4.
Ruddy S; Gigli I; Austen KF
N Engl J Med; 1972 Sep; 287(13):642-6. PubMed ID: 4561829
[No Abstract] [Full Text] [Related]
22. [RELATIONS BETWEEN SYSTEMIC LUPUS ERYTHEMATOSUS AND AUTOIMMUNE BLOOD DISEASES].
PIZZI F; CARRARA PM; ERIDANI S
Reumatismo; 1964; 16():381-7. PubMed ID: 14279390
[No Abstract] [Full Text] [Related]
23. [SOME PROBLEMS OF MEDICAL METHODS IN CORTICOSTEROID THERAPY].
KASSIRSKII Ia; MILEVSKAIA IuL
Ter Arkh; 1964 Jan; 36():3-16. PubMed ID: 14149442
[No Abstract] [Full Text] [Related]
24. [Acquired auto-immune hemolytic anemia associated with systemic lupus erythematosus].
Tomov L; Ilieva V; Elenko A; Tsolov Ts
Vutr Boles; 1972; 11(1):84-7. PubMed ID: 4679935
[No Abstract] [Full Text] [Related]
25. QUANTITATIVE STUDIES OF THE EFFECT OF RED-BLOOD-CELL SENSITIZATION ON IN VIVO HEMOLYSIS.
CONSTANTOULAKIS M; COSTEA N; SCHWARTZ RS; DAMESHEK W
J Clin Invest; 1963 Nov; 42(11):1790-801. PubMed ID: 14083168
[No Abstract] [Full Text] [Related]
26. [Immunosuppressive therapy].
Nelius D; Stieglitz R
Z Arztl Fortbild (Jena); 1971 Jul; 65(14):742-6. PubMed ID: 5123062
[No Abstract] [Full Text] [Related]
27. [Research on the role of heredity in production of some diseases with autoimmune characteristics].
Fodor O; Pârău N; Nicoară G
Med Interna (Bucur); 1971 Jan; 23(1):37-50. PubMed ID: 5550272
[No Abstract] [Full Text] [Related]
28. Direct antiglobulin (Coombs) test in systemic lupus erythematosus patients.
Skare T; Picelli L; Dos Santos TAG; Nisihara R
Clin Rheumatol; 2017 Sep; 36(9):2141-2144. PubMed ID: 28762061
[TBL] [Abstract][Full Text] [Related]
29. Mycoplasma (PPLO), leukemia and autoimmune disease.
Barile MF
Wistar Inst Symp Monogr; 1965 Sep; 4():171-85. PubMed ID: 5894361
[No Abstract] [Full Text] [Related]
30. How the body works against itself... autoimmune diseases.
Glasser RJ
Nursing; 1977 Sep; 7(9):38-43. PubMed ID: 587264
[No Abstract] [Full Text] [Related]
31. LUPUS ERYTHEMATOSUS PRESENTING AS HEMOLYTIC ANEMIA; REPORT OF A CASE AND REVIEW OF CLINICAL ASPECTS.
HAUSER TE
Rocky Mt Med J; 1963 Nov; 60():31-3 PASSIM. PubMed ID: 14080302
[No Abstract] [Full Text] [Related]
32. Systemic lupus erythematosus -- hematological aspects.
Schreiber AD
J Rheumatol; 1980; 7(3):395-7. PubMed ID: 6995609
[No Abstract] [Full Text] [Related]
33. [Immunosuppressive therapy].
Purice S
Stud Cercet Med Interna; 1973; 14(3):209-16. PubMed ID: 4574134
[No Abstract] [Full Text] [Related]
34. [Emergency situations in rheumatology].
Nasonova VA
Sov Med; 1972 Feb; 35(2):9-15. PubMed ID: 4402666
[No Abstract] [Full Text] [Related]
35. [Hemolytic anemias observed in SLE].
Ichikawa Y; Tanaka C; Ohya N; Hida M
Nihon Rinsho; 1996 Sep; 54(9):2528-33. PubMed ID: 8890589
[TBL] [Abstract][Full Text] [Related]
36. Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus.
Chan AC; Sack K
J Rheumatol; 1991 Feb; 18(2):280-2. PubMed ID: 2023224
[TBL] [Abstract][Full Text] [Related]
37. [HEMATOLOGIC AND DIAGNOSTIC ASPECTS OF OUR CASES OF SYSTEMIC LUPUS ERYTHEMATOSUS (BASED ON A 4-YEAR OBSERVATION OF 22 PATIENTS)].
LUDWIG K; ZSAMBEKY P; ISTVAN L
Orv Hetil; 1964 Jun; 105():1058-63. PubMed ID: 14157254
[No Abstract] [Full Text] [Related]
38. Treatment of immune-mediated disease.
Aucoin DP
Vet Clin North Am Small Anim Pract; 1982 Feb; 12(1):61-6. PubMed ID: 7048714
[No Abstract] [Full Text] [Related]
39. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.
Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL
Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001
[TBL] [Abstract][Full Text] [Related]
40. [Histological biopsy bone marrow studies on the morphology of immune reaction in autoimmune diseases].
Schneider D; Schwenke P; Schwenke H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(1):54-63. PubMed ID: 4118781
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
